Single answer
Is Amgen Inc (AMGN) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.08 or 8.20%
(In 16 weeks 2 days 19 hours 41 minutes and 17 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Amgen Inc is $347.00, which is $37.33 (9.71%) below the current price today's price.
Low target: $185.00 | High target: $432.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Amgen Inc discovers develops manufactures and delivers human therapeutics worldwide It focuses on inflammation oncologyhematology bone health cardiovascular disease nephrology and neuroscience areas The companys products include Enbrel to treat plaque psoriasis rheumatoid arthritis and psoriatic arthritis Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer Prolia to treat postmenopausal women with osteoporosis Xgeva for skeletalrelated events prevention Otezla for the treatment of adult patients with plaque psoriasis psoriatic arthritis and oral ulcers associated with Behcets disease Aranesp to treat a lowerthannormal number of red blood cells and anemia KYPROLIS to treat patients with relapsed or refractory multiple myeloma and Repatha which reduces the risks of myocardial infarction stroke and coronary revascularization It also markets Nplate Vectibix MVASI Parsabiv EPOGEN KANJINTI BLINCYTO Aimovig EVENITY AMGEVITATM SensiparMimpara NEUPOGEN IMLYGIC Corlanor and AVSOLA Amgen Inc serves healthcare providers including physicians or their clinics dialysis centers hospitals and pharmacies It distributes its products through pharmaceutical wholesale distributors as well as directtoconsumer channels It has collaboration agreements with Novartis Pharma AG UCB Bayer HealthCare LLC BeiGene Ltd Eli Lilly and Company Datos Health and Verastem Inc to evaluate VS6766 in combination with lumakrastm Sotorasib in patients with KRAS G12Cmutant nonsmall cell lung cancer It has an agreement with Kyowa Kirin Co Ltd to jointly develop and commercialize KHK4083 a Phase 3ready antiOX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases and research and development collaboration with Neumora Therapeutics Inc and Plexium Inc Amgen Inc was incorporated in 1980 and is headquartered in Thousand Oaks California
Website: https://www.amgen.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.60. Cash flow to debt ratio: 0.18. Net profit margin: 20.97%. Inflation risk score: low (0.45/1).
Dividend history check
Yes, Amgen Inc pays dividends. Last payment was 2026-03-06 for holders on 2026-02-13. Over 59 payments between 2011 and 2026, total $79.92 with an average of $1.355 per share. Last dividend was $2.52.
Trading liquidity
Yes, the average daily trading liquidity for Amgen Inc is $910.5M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Amgen Inc, 2016-02-26 had a stock price of $147.60. If you invested back then, your return now would be a profit of $236.73 per share or 160.39%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.